Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Lovenox (enoxaparin sodium) Injection
Company: Sanofi-Aventis U.S. Inc.
NDA: 022138 and 020164/s75
Approval Date: 5/16/2007


Date created: March 24, 2009

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.